Viewing Study NCT01817751


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-03-02 @ 4:01 PM
Study NCT ID: NCT01817751
Status: COMPLETED
Last Update Posted: 2024-07-17
First Post: 2013-03-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
Sponsor: Virginia Commonwealth University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma View
None Recurrent Adult Brain Neoplasm View
None Malignant Glioma View
None WHO Grade III Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None central nervous system View
None Brain and Nervous System View